Deficiency of invariant natural killer T cells in coeliac disease

Gut

Volumn 56, Issue 6, 2007, Pages 790-795

  Grose, R H ^b   Cummins, A G ^a,b   Thompson, F M ^b  

^a DX 465384 ^*  (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD3 ANTIBODY; INTERLEUKIN 4; MESSENGER RNA; TETRAMER;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CELIAC DISEASE; CONTROLLED STUDY; DUODENUM BIOPSY; FLOW CYTOMETRY; HUMAN; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; NATURAL KILLER T CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELIAC DISEASE; CELLS, CULTURED; DUODENUM; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-4; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MIDDLE AGED; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 34249788416     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.095307     Document Type: Article

References (38)

1. Housely J, Asquith P, Cooke W. Immune response to gluten in adult coeliac disease. Br Med J 1969;2:159-61.
2. Ferguson A, MacDonald TT, McClure JP, et al. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet 1975;i:895-7.
3. Sigora K, Anand BS, Truelove SC, et al. Stimulation of lymphocytes from patients with coeliac disease by a sub-fraction of gluten. Lancet 1976;ii:389-91.
4. Penttila IA, Gibson CE, Forrest BD, et al. Lymphocyte activation as measured by inlerleukin-2 receptor expression to gluten antigen in coeliac disease. Immunol Cell Biol 1990;68:155-60.
5. Marsh MN, Cummins AG. The interactive role of mucosal T lymphocytes in intestinal growth, development and enteropathy. J Gastroenterol Hepatol 1993;8:270-8.
6. Lundin KE, Scott H, Hansen T, et al. Gliadin-specific, HLA-DQ(alpha*0501, beta*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187-96.
7. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-42.
8. Anderson RP, Degano P, Godkin AJ, et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T cell epitope. Nat Med 2000;6:337-42.
9. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:776-8.
10. Molberg Ø, MacAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713-17.
11. Van de Wal Y, Kooy Y, van Veelen P, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585-8.
12. Nilsen EM, Gjertsen HA, Jensen K, et al. Gluten activation of peripheral blood T cells induces a Th0-like cytokine pattern in both coeliac patients and controls. Clin Exp Immunol 1995;103:295-303.
13. Meresse B, Chen Z, Ciszewski C, et al. Coordinated induction by IL-15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004;21:357-66.
14. Hüe S, Mention J-J, Monteiro RC, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-7.
15. Pender SLF, Tickle SP, Docherty AJP, et al. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-90.
16. Mowat AM, Lamont AG, Strobel S, et al. The role of antigen processing and suppressor T cells in immune responses to dietary proteins in mice. Adv Exp Med Biol 1987;216A:709-20.
17. Pignata C, Troncone R, Monaco G, et al. Impaired suppressor activity in children affected by coeliac disease. Gut 1985;26:285-90.
18. Corazza GR, Sarchielli P, Londei M, et al. Gluten specific suppressor T cell dysfunction in coeliac disease. Gut 1986;27:392-8.
19. Sumida T, Sakamoto A, Murata H, et al. Selective reduction of T cells bearing invariant V-alpha-24J alpha-Q antigen receptor in patients with systemic sclerosis. J Exp Med 1995;182:1163-8.
20. Baxter AG, Kinder SJ, Hammond KJ, et al. Association between alpha beta TCR+ CD4- CD8- T cell deficiency and IDDM in NOD/Lt mice. Diabetes 1997;46:572-82.
21. Wilson SB, Kemi SC, Patton KT, et al. Extreme Th1 bias of invariant Vα24JαQT cells in type 1 diabetes. Nature 1998;391:177-81.
22. Illes Z, Kondo T, Newcombe J, et al. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 2000;164:4375-81.
23. Godfrey DI, Hammond KJL, Poulton LD, et al. NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-83.
24. Zhang B, Yamamura T, Kondo T, et al. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 1997;186:1677-87.
25. Frey AB, Rao TD. NK T cell cytokine imbalance in murine diabetes mellitus. Autoimmunity 1999;29:201-14.
26. Trop S, Samsonov D, Golsman I, et al. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology 1999;29:746-55.
27. Saubermann LJ, Beck P, De Jong Y, et al. Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 2000;119:119-28.
28. Matsuda JL, Naidenko OV, Gapin L, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000;192:741-54.
29. Mendiratta SK, Martin WD, Hong S, et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997;6:469-77.
30. Singh N, Hong S, Scherer DC, et al. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999;163:2373-7.
31. Takahashi T, Nieda M, Koezuka Y, et al. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2000;164:4458-64.
32. Hadziselimovic F, Emmons LR, Schaub U, et al. Occurrence of large granular lymphocytes and natural killer cells in the epithelium of the gut distinguishes two different coeliac diseases. Gut 1992;33:767-72.
33. Di Sabatino A, Bertrandi E, Casadei Maldini M, et al. Phenotyping of peripheral blood lymphocytes in adult coeliac disease. Immunology 1998;95:572-6.
34. Van der Vliet HJ, von Blomberg BM, Nishi N, et al. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001;100:144-8.
35. Jordan MA, Fletcher J, Baxter AG. Genetic control of NKT cell numbers. Immunol Cell Biol 2004;82:276-84.
36. Berzin SP, Uldrich AP, Pellicci DG, et al. Parallels and distinctions between T and NKT cell development in the thymus. Immunol Cell Biol 2004;82:269-75.
37. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999;117:297-303.
38. Wilson SB, Kent SC, Horton HF, et al. Multiple differences in gene expression in regulatory Vα24JαQ T cells from identical twins discordant for type 1 diabetes. Proc Natl Acad Sci U S A 2000;97:7411-16.